Literature DB >> 16702047

Why human platelets fail to kill bacteria.

James G White1.   

Abstract

Recent investigations have suggested that bacteria are taken up by platelets in the same manner as by polymorphonuclear (PMN) leukocytes and monocytes. The phagocytic vacuole containing the organism is completely separated from the cell exterior and the cytoplasm in order to form a killing chamber. Yet, earlier studies demonstrated that platelets do not kill bacteria. The present work has provided a basis for the lack of platelet bactericidal activity. Platelets incubated with Staphylococcus aureus 502A or RN 450 for intervals up to 2 h can take up organisms into sequestration vacuoles that resemble the phagosomes formed by PMN and monocytes. However, staining with tannic acid which forms an electron dense stain with osmic acid reveals that the phagosomes in PMN and monocytes are completely separated from the cell exterior and the cytoplasm. As a result, they are true killing chambers. The engulfment vacuoles containing bacteria in platelets on the other hand are almost never sealed from the cell exterior. Osmium black reaction product stains the inside of the engulfment vacuole and channels of the open canalicular system connecting it to the cell exterior. Thus platelets do not form the killing chamber phagosomes observed in leukocytes and, as a result, cannot kill bacteria.

Entities:  

Mesh:

Year:  2006        PMID: 16702047     DOI: 10.1080/09537100500441234

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  13 in total

1.  Internalization of IgG-coated targets results in activation and secretion of soluble CD40 ligand and RANTES by human platelets.

Authors:  Adam J Antczak; Joshua A Vieth; Navinderjit Singh; Randall G Worth
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

2.  Human platelet FcγRIIA and phagocytes in immune-complex clearance.

Authors:  Zhen-Yu Huang; Paul Chien; Zena K Indik; Alan D Schreiber
Journal:  Mol Immunol       Date:  2010-12-17       Impact factor: 4.407

3.  Drug delivery using platelet cancer cell interaction.

Authors:  Sounik Sarkar; Mohammed Aftab Alam; Jyoti Shaw; Anjan Kr Dasgupta
Journal:  Pharm Res       Date:  2013-06-06       Impact factor: 4.200

Review 4.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

Review 5.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

Review 6.  Platelets and Their Interactions with Other Immune Cells.

Authors:  Fong W Lam; K Vinod Vijayan; Rolando E Rumbaut
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

7.  Assessment of platelet activation and phagocytic activity in gastric cancer patients.

Authors:  Joanna Matowicka-Karna; Zbigniew Kamocki; Halina Kemona
Journal:  World J Gastrointest Pathophysiol       Date:  2013-02-15

8.  Magnetic and contrast properties of labeled platelets for magnetomotive optical coherence tomography.

Authors:  Amy L Oldenburg; Caterina M Gallippi; Frank Tsui; Timothy C Nichols; Kellie N Beicker; Raghav K Chhetri; Dmitry Spivak; Aaron Richardson; Thomas H Fischer
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

9.  Novel anti-bacterial activities of β-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation.

Authors:  Bjoern F Kraemer; Robert A Campbell; Hansjörg Schwertz; Mark J Cody; Zechariah Franks; Neal D Tolley; Walter H A Kahr; Stephan Lindemann; Peter Seizer; Christian C Yost; Guy A Zimmerman; Andrew S Weyrich
Journal:  PLoS Pathog       Date:  2011-11-10       Impact factor: 6.823

Review 10.  Are Platelets Cells? And if Yes, are They Immune Cells?

Authors:  Olivier Garraud; Fabrice Cognasse
Journal:  Front Immunol       Date:  2015-02-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.